We have developed highly specific antisera by immunizing rabbits with cholylglycine and chenodeoxycholylglycine covalently coupled to bovine serum albumin. The acquisition of these antibodies and the commercial availability of a 14C tracer for cholic acid conjugates enabled us to develop a single-tube RIA for these classes of conjugated bile acids.
In this paper we report the development, validation, and application of this method to healthy subjects and to patients with liver disease. A correlation with the conventional liver-function tests is then reported.
Materials and Methods

Reagents
All reagents were of analytical grade, obtained from usual commercial sources.
Potassium phosphate buffer (pH = 7.4 at 22 #{176}C) concentration was 10 mmol/liter.
Serum free of bile acids was prepared according to the method of Simmonds et al. (5) , which provided a serum 99% free from bile acids. [ 
1-'4C]Glycocholic acid and [U-3H]glycochenodeoxycholic
acid were used as markers of their complete extraction.
(NH4)2S04: saturated solution. Scintillation cocktail ("Unisolve"; Koch-Light Lab., Ltd., England): 15 ml/sample.
Preparation of Antigen and Antibody
Four New Zealand rabbits were immunized with chenodeoxycholylglycine and four with cholylglycine during five months. The carbodiimide method was applied in order to couple bile acids with proteins (5) . The molar ratio albumin/bile acid was 1/, to 1/15 for both of the bile acids.
The removal of free bile acids has proved to be useless. Each antigen was emulsified with Freund's complete adjuvant (1/1 by vol) and injected subcutaneously in five areas of the animals' backs, according to Simmonds et al. (5) .Subsequent injections of the same dose were repeated weekly.
Twice a month, 5 ml of blood was drawn by cardiac too,
The serum thus obtained was sterilized by passage through a 0.22-nm (av pore diameter) filter (Miflipore Corp. Bedford, Mass. 01730), lyophilized, and stored at 4 #{176}C. Under such conditions, antisera were stable for at least a year; reconstitution with phosphate buffer did not significantly alter the titer.
Antisera were used without any further purification.
Antisera for cholylglycine and chenodeoxycholylglycine provided about 40% bound (B/T)0 when respectively diluted 300-and 500-fold with buffer.
Other Procedures
Tracers: [1-'4C]Glycocholic acid (51.7 Ci/mol) (The Radiochemical Centre, Amersham, England, HP79LL) and [U-3Hjglycochenodeoxycholic acid (5.0 kCi/mol) (New England Nuclear, Worcester, Mass. 01608) were proved to be 97-99% pure by thin-layer chromatographic zonal scanning (16) .
For the simultaneous determination of the two bile acids, about 10 000 dpm for [3H]chenodeoxycholylglycine (-'600 pg/tube) and 1000 dpm for [1-'4C]cholylglycine (-6000 pg/tube) were used in each tube, diluted in phosphate buffer.
Standards. Stock solutions, 0.2 mmol/liter in phosphate buffer, were stored at -20 #{176}C. Properly diluted with bile acid-free serum (10-fold diluted in phosphate buffer), they provided a series of solutions from 5 to 160 pmol/tube. Concentrated solutions were measured by enzymatic determination, with use of 3a-hydroxysteroid dehydrogenase (EC 1.1.1.50) (18) , and proved to be stable if stored at -20 #{176}C.
Procedure for double RIA. The serum samples for analysis were diluted five-and 10-fold when obtained from normal subjects, and 50-to 200-fold when obtained from patients with liver disease.
Bile-acid-free serum (100 tl, diluted threefold with phosphate buffer) and 200 l of each tracer were added to each tube, followed by 100 l of each standard solution (or sample). Finally, 100 tl of each antiserum, properly diluted, and 100 il of phosphate buffer were added.
Blanks consisted of the following: B00: 100 il of bile acid-free serum (diluted threefold with phosphate buffer), 200 tl of each tracer, 100 l of bile acid-free serum (diluted 10-fold with phosphate buffer), and 400 l of phosphate buffer.
B0: 100 jl of bile-acid-free serum (diluted threefold with phosphate buffer), 200 tl of each tracer, 100 l of each antiserum, 100 jl of bile-acid-free serum diluted 10-fold, and 200 sl of phosphate buffer. Each tube was vortex-mixed strongly, and 1 ml of saturated (NH4)2S04 was added to all samples after 3 h at room temperature (further incubation did not result in a higher fraction of tracer bound, Figure 1 ). The contents of the tubes were stirred again and centrifuged at 3500 rpm for 25 mm at room temperature.
The two bile acids were separately determined as described by Simmonds et al. (5) .
Liquid scintillation counting.
The counting was Samples were counted with an Analytic Isocap 300 Liquid Scintillation Counter (Searle Analytic Inc., Des Plaines, Ill. 60018). Both isotopes were simultaneously counted, during a single counting period, in two analyzer channels (A3 for the low-energy isotope, B3 for the high-energy isotope).
All the samples, counted for 10 mm, gave a mean efficiency of 36% for 3H and 46% for '4C.
Only three efficiency calibration curves were required because of the minimal and uniform quenching in all samples: the % efficiency vs. ESR curve for low-energy isotope, as counted in channel A3; the % efficiency vs. ESR curve for the high-energy isotope, as counted in channel A3; and the % efficiency vs. ESR curve for the high-energy isotope as counted in channel B3.
When: h1 = % efficiency/100, the fractional efficiency for the low-energy isotope in channel A3, Ci = % efficiency/100, the fractional efficiency for the high-energy isotope in channel A3, C2 = % efficiency/100, the fractional efficiency for the high-energy isotope in channel B3, 3H-cpmA = count/mm, as counted in channel A3, for H3, and '4C-cpm8 = count/mm, as counted in channel B3 for 14C, then disintegrations per minute for 14 (Dr) and for 3H (DH) are determined as follows:
Calculation.
The antibody-bound fraction was expressed as a percentage of B/B0 vs. log dose. The doseresponse curve has been described by a four-parameter logit function( 1 7 for 50% dose-response) (pmol/tube), and b = slope factor.
The best sigmoidal curve was computed by the least-squares method and the amount of each bile acid was interpolated automatically by use of a suitable computer program.
Subjects
Concentrations
of the two conjugated bile acids (Lmolfliter) were determined for 20 control subjects, 20 patients with liver cirrhosis, and 20 patients with obstructive jaundice. Liver disease had been previously assessed by liver biopsy and conventional liver-function tests. Diagnosis of obstructive jaundice had been confirmed surgically.
The sera were separated and stored at -20 #{176}C in glass vials until analyzed.
Results
Specificity.
Simultaneous determination of the two bile acids was possible because of the high specificity of the two antisera. Table 1 shows the cross reaction of the two antisera with the other bile acids normally found in human serum. In each tube, the concentration of the bile acids added ranged from 40 to 640 pmol/tube. No cross reaction was found between the two antisera and the other bile acids; they cross reacted with their own respective unconjugated antigen only to a very limited extent (Table 1 ). The antisera reacted equally to glycine and taurine conjugates. Standard curve. Figure 2 shows the dose-response curves for the two classes of bile acids in single and simultaneous determinations. Each point represents the mean value of 10 determinations ± 1 SD. The midrange (Table 2 ) of the [U-3H]glycocholic acid (c = 21.05 ± 6.3) dose-response curves did not significantly differ when single determinations were carried out. For the former dose-response curve, simultaneous determination did not appear to affect the midrange (c = 20.4 ± 6.8). When 1-14C]glycocholic acid was used as tracer; however, the dose-response curve midrange was higher than for [U-3H]glycocholic, both when single (c = 41.4 ± 9.5) and simultaneous (c = 57.9 ± 9.0) determinations were done. Simultaneous determination also did not appear to affect the value of the dose-response curve midrange when a 14C-labeled tracer was used ( Table 2) .
The slopes of the curves appeared to be greater for the [U-3H]glycochenodeoxycholic acid than for [1-'4C]-glycocholic acid. All the points of the composite standard curve differed significantly from one another, and the coefficients of variation were 8% or less. The smallest amount of unlabeled antigen that could be distinguished from no antigen was 5 pmol/tube for conjugated chenodeoxycholic acid (CCDCA) assay and 10 pmol/tube for conjugated cholic acid acid (CCA) assay.
No interference of 3H with 14C counting was found, while 14Cinterference on 3H counting was minimized tope's count) of the high-energy isotope's disintegration rate, while the low-energy isotope's disintegration rate required a correction for the high-energy isotope's count.
The simultaneous determination of the two standard curves, where the proportion of the two antigens were inverted, so that CCA/CCDCA ratio varied within a wider range than in human normal serum, confirmed no interference of the two isotopes on each other when the low-energy isotope dpm was properly corrected for the high-energy one (Figure 3 ).
Bile acids in tested serum. Simultaneous and single determination of each sample gave identical values, as also was true for those sera with inverted CCA/CCDCA ratio ( Figure 4) . Concentrations of each of the two conjugated bile acids, assessed by simultaneous determination, appear in Figure 6 , and values for them in serum as well as other liver-function tests are in Table 3 ; in pathological conditions, serum bile acids were increased in cases where results for the other liver-function tests were normal (Figures 7 and 8, Table 3 ).
In obstructive jaundice both conjugated cholic acid (P < 0.001) and conjugated chenodeoxycholic acid (P <0.01) were related with bilirubin values, as well as with 'y-glutamyltransferase (EC 2.3,2.
2) values (P <0.01 and P < 0.1, respectively). In cirrhotic between conjugated patients a high correlation was found internal standard (21 ) . Figure 10 shows the analysis of chenodeoxycholic acid and biliruregression; it reveals a close agreement of values at the bin (P < 0.01) and an even better correlationbetween highest concentrations, while at the lowest concentraconjugated chenodeoxycholic acid and -y-glutamyl--tions, the gas-chromatographic method is at the limit transferase(P < 0.001).
of sensitivity. A good correlation was found when conjugated cholic
The intra-assay precision, verified in 20 determinaacid values were plotted vs. bilirubin (P < 0.1) and ytions of the samples in the same assay, was satisfactory; glutamyltransferase (P < 0.05). the coefficient of variation was 8% or less at the lowest No significant relationship was found with the other concentration of bile acids. The intra-assay precision liver-function tests. was estimated in the samples from a normal subject and Parallelism.
Samples with high bile-acid concena patient with cirrhosis, measured in 10 different assays. trations (cirrhosis) were diluted 20-, 40-, 80-, 120-, and
The coefficient of variation was 13% at the lowest con-160-fold, to study the behavior of the antibody in centration and 5.5% at the highest concentration of bile comparison to a standard curve for both. The plot of acids. standard dilution vs. tracer binding (Figure 9) paralleled Analytical recovery. In 10 samples from control the standard curves, which indicated that the antibody subjects, to which an amount of cholylglycine and chewas reacting only with the bile acid that represented its nodeoxycholylglycine equal to 0.2 mol/liter was added, own antigen.
recovery ranged from 96 to 107%. Accurancy and precision. Serum bile acids from 15 unknown samples were determinated both by raDiscussion dioimmunoassay and by gas chromatography (17) . Bile
Results show the validity of the proposed method. acids were extracted from the sera with Amberlite Simultaneous determination of the two bile acids was XAD2 (20) .After saponification of the extract, bile acid possible because of the high specificity of the two antimethyl acetyl derivatives were detected by use of a 2 m sera. X 0.4 cm glass column packed with 3% AN 600 on AnThis method has been proved to be both sensitive, akrom Q (110-120 mesh), with nordeoxycholic acid as specific, and easily done. In fact, no preliminary pro-
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Bilirubin, mg/lIter ii: II lI2. ) cedure is required. The tracers, as well as the other reagents, can be obtained from the usual commercial sources; and only a short analysis time and small serum samples are required. Simultaneous determination of the two classes of bile acids did not seem to affect the sensitivity of the assay; when a proper 14C/H3 ratio was used, good results were achieved.
Use of a '4C-labeled tracer resulted in a less-sensitive dose-response curve, because of the lower specific activity of a 14C-tracer;but use of such tracer does not compromise the sensitivity of the assay to such an extent as to cause it to operate at the lower limit of sensi-
tivity.
In normal as well as in certain pathological conditions, such as cirrhosis and chronic active liver disease, the CCA/CCDCA ratio is less than unity, because chenodeoxycholic acid is the major bile acid in serum; cholic acid predominates in jaundice. By simultaneous determination ofthe two primary bile acids, it is possible to learn their ratio in serum by a single assay.
It is not the aim of the present paper to assess the validity of measuring serum conjugated cholic acid and conjugated chenodeoxycholic acid as an index of liver function. Nevertheless, in all the patients with cirrhosis of the liver or obstructive jaundice that we have examined, serum conjugated cholic acid and conjugated chenodeoxycholic acid values are increased, while other usual liver-function tests give an abnormal result in a smaller percentageof cases ( Table 3 ), confirming that increased serum conjugated cholic acid and conjugated chenodeoxycholic acid is the most sensitive liverfunction test, and that an inverted conjugated cholic acid/conjugated chenodeoxycholic acid ratio (i.e., >1) is a marker of jaundice.
Our results appear in good agreement with those (4-7, 19,20) of many authors (Figure 11) , which confirms the validity of the present method as well as its applicability in diagnosis of hepatobiliary disease.
